Efficacy of donor screening for HTLV-I and the natural history of transfusion-transmitted infection

Transfusion

Volumn 39, Issue 10, 1999, Pages 1104-1110

  Inaba, Shoichi ^a   Okochi, K ^b   Sato, H ^b   Fukada, K ^b   Kinukawa, N ^b   Nakata, H ^b   Kinjyo, K ^b   Fujii, F ^b   Maeda, Y ^b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CHILD; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; SCREENING; SEROCONVERSION; SPINAL CORD DISEASE; SURVIVAL RATE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGGLUTINATION TESTS; BLOOD DONORS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HTLV-I INFECTIONS; HUMANS; INFANT; MALE; MASS SCREENING; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; SEROLOGIC TESTS; SURVIVAL ANALYSIS; UVEITIS;

EID: 0032843037     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39101104.x     Document Type: Article

References (20)

1. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T cell leukemia virus by blood transfusion: seroconversion in recipients. Vox Sang 1984;46:245-53.
2. Inaba S, Sato H, Okochi K, et al. Prevention of transmission of human T-lymphotropic virus type 1 (HTLV-1) through transfusion, by donor screening with antibody to the virus. One-year experience. Transfusion 1989;29:7-11.
3. Williams AE, Fang CT, Slamon DJ, et al. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. Science 1988;240:643-6; erratum appears Science 1989;244:757.
4. Cohen ND, Munoz A, Reitz BA, et al. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl J Med 1989;320:1172-6.
5. Shih JW, Lee HH, Falchek M, et al. Transfusion-transmitted HTLV-I/II infection in patients undergoing open-heart surgery. Blood 1990;75:546-9.
6. Vrielink H, Zaaijer HL, Reesink HW. The clinical relevance of HTLV type I and II in transfusion medicine. Transfus Med Rev 1997;11:173-9.
7. Ikeda M, Fujino R, Matsui T, et al. A new agglutination test for serum antibodies to adult T-cell leukemia virus. Gann 1984;75:845-8.
8. Fujino R, Kawato K, Ikeda M, et al. Improvement of gelatin particle agglutination test for detection of anti-HTLV-I antibody. Jpn J Cancer Res 1991;82:367-70.
9. Kuroda N, Washitani Y, Shiraki H, et al. Detection of antibodies to human T-lymphotropic virus type I by using synthetic peptides. Int J Cancer 1990;45:865-8.
10. Lal RB, Rudolph DL, Griffis KP, et al. Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I. J Virol 1991;65:1870-6.
11. Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci U S A 1981;78:6476-80.
12. Miyoshi I, Kubonishi I, Sumida M, et al. A novel T-cell line derived from adult T-cell leukemia. Gann 1980;71:155-6.
13. Miyakoshi H, Sugimoto M, Igarashi H, et al. Improvement of simultaneous detection of antibodies to Gag and envelope antigens of human T-lymphotropic virus type I by western immunoblot assay. J Clin Microbiol 1992;30:2555-9.
14. Gasmi M, D'Incan M, Desgranges C. Transfusion transmission of human T-lymphotropic virus type I (HTLV-I) from an asymptomatic blood donor conservation of LTR U3, env, and tax nucleotide sequences in a recipient with HTLV-I-associated myelopathy. Transfusion 1997;37:60-4.
15. Rosner B. Fundamentals of biostatistics. Boston: PWS-Kent Pub. Co., 1998:176-8.
16. Osame M, Janssen R, Kubota H, et al. Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 1990;28:50-6.
17. Vamvakas EC, Taswell HF. Long-term survival after transfusion. Transfusion 1994;34:471-7.
18. Imamura Y, Inoue F, Michishoio M, et al. The change of anti HTLV-1 positive rate in recent 8 years among blood donors in Kumamoto, Japan. Presented at the 24th Congress of the International Society of Blood Transfusion, Makuhari, Tokyo, 1996.
19. Sakai Y, Yao H, Sadoshima S, et al. Development of HTLV-I associated myelopathy (HAM) in a seroconverted patient for antibody to HTLV-I (letter). J Neurol Neurosurg Psychiatry 1989;52:1445.
20. Ono A, Miura T, Araki S, et al. Subtype analysis of HTLV-1 in patients with HTLV-1 uveitis. Jpn J Cancer Res 1994;85:767-70.